secwatch.observer — SEC 8-K summary
======================================

Issuer:     AFLAC INC (AFL)
CIK:        0000004977
Form:       8-K
Filed at:   2026-11-04T21:20:48+00:00
Accession:  0001628280-26-070181
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Aflac Q3 net earnings $303M (-81.5%) on $1.1B investment losses; adjusted EPS $2.43 (-2.4%); dividend up to $0.61
--------------------------------------------------------------------------------

- Net earnings $303M ($0.61/diluted share) vs $1.6B ($3.08) a year ago, driven by $1.1B net investment losses ($2.15/sh) from strategic portfolio repositioning; total revenues -31.0% to $3.3B.
- Adjusted earnings $1.2B (-8.5%), aided by $453M reserve remeasurement gains; 6.8% weaker yen (158.49 vs 147.68) cut adjusted EPS by $0.03; annualized ROE 4.1%, adjusted ROE ex-FX 23.7%.
- Aflac U.S. pretax adjusted earnings $493M (+31.5%), profit margin 27.7% vs 21.7%; net earned premiums +3.3% to $1.5B; U.S. sales +3.5% to $403M on dental, group life and disability.
- Aflac Japan pretax adjusted earnings ¥152.3B (-15.2%), margin 44.4% vs 52.2%; premiums -2.0% to ¥240.3B; sales -4.0% to ¥18.8B; ceded ~¥500B of cancer reserves to Aflac Re Bermuda.
- Q4 dividend $0.61/share payable Dec 1, 2026 (record Nov 18), marking 44 straight years of increases; Q3 capital return $1.1B = $804M buybacks + $305M dividends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/4977/000162828026070181/0001628280-26-070181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/4977/000162828026070181/afl-20261104.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-070181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer